Cytokinetics (CYTK) Tops Q3 EPS by 8c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 63.60 +1.29 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.31 | 52 Week High | $13.18 | |||
| Open | $64.06 | 52 Week Low | $6.00 | |||
| Day High | $64.96 | P/E | N/A | |||
| Day Low | $60.98 | EPS | $-1.24 | |||
| Volume | 2,917,188 | |||||
